A platform for research: civil engineering, architecture and urbanism
Emerging Targets in Type 2 Diabetes and Diabetic Complications
Type 2 diabetes is a metabolic, chronic disorder characterized by insulin resistance and elevated blood glucose levels. Although a large drug portfolio exists to keep the blood glucose levels under control, these medications are not without side effects. More importantly, once diagnosed diabetes is rarely reversible. Dysfunctions in the kidney, retina, cardiovascular system, neurons, and liver represent the common complications of diabetes, which again lack effective therapies that can reverse organ injury. Overall, the molecular mechanisms of how type 2 diabetes develops and leads to irreparable organ damage remain elusive. This review particularly focuses on novel targets that may play role in pathogenesis of type 2 diabetes. Further research on these targets may eventually pave the way to novel therapies for the treatment—or even the prevention—of type 2 diabetes along with its complications.
Emerging Targets in Type 2 Diabetes and Diabetic Complications
Type 2 diabetes is a metabolic, chronic disorder characterized by insulin resistance and elevated blood glucose levels. Although a large drug portfolio exists to keep the blood glucose levels under control, these medications are not without side effects. More importantly, once diagnosed diabetes is rarely reversible. Dysfunctions in the kidney, retina, cardiovascular system, neurons, and liver represent the common complications of diabetes, which again lack effective therapies that can reverse organ injury. Overall, the molecular mechanisms of how type 2 diabetes develops and leads to irreparable organ damage remain elusive. This review particularly focuses on novel targets that may play role in pathogenesis of type 2 diabetes. Further research on these targets may eventually pave the way to novel therapies for the treatment—or even the prevention—of type 2 diabetes along with its complications.
Emerging Targets in Type 2 Diabetes and Diabetic Complications
Demir, Sevgican (author) / Nawroth, Peter P. (author) / Herzig, Stephan (author) / Ekim Üstünel, Bilgen (author)
Advanced Science ; 8
2021-09-01
23 pages
Article (Journal)
Electronic Resource
English
Long Noncoding RNAs in Diabetes and Diabetic Complications
British Library Online Contents | 2018
|MicroRNA and Diabetic Complications: A Clinical Perspective
British Library Online Contents | 2018
|Analysis of Prevalence of Chronic Diabetic Complications and Associated Factors
British Library Conference Proceedings | 2006
|Epigenetic Contribution to the Development and Progression of Vascular Diabetic Complications
British Library Online Contents | 2018
|